Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalvis Hornburg

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Sports Medicine Reports|July 1, 2026
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative ReviewChantal Nguyen, Matthew R Allen, Kalvis Hornburg, et al.
Current Reviews in Musculoskeletal Medicine|July 11, 2026
Concussion: A Comprehensive Review of Current EvidenceKalvis Hornburg, Claire E Cassianni, Shaheed M Muhammad, et al.
Nature Communications|June 7, 2017
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agentsChoi-Fong Cho, Justin M Wolfe, Colin M Fadzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple MyelomaIrene M Ghobrial, Chia-Jen Liu, Robert A Redd, et al.
American Journal of Hematology|February 19, 2019
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk groupMark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Sports Medicine Reports|July 1, 2026
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative ReviewChantal Nguyen, Matthew R Allen, Kalvis Hornburg, et al.
Current Reviews in Musculoskeletal Medicine|July 11, 2026
Concussion: A Comprehensive Review of Current EvidenceKalvis Hornburg, Claire E Cassianni, Shaheed M Muhammad, et al.
Nature Communications|June 7, 2017
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agentsChoi-Fong Cho, Justin M Wolfe, Colin M Fadzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple MyelomaIrene M Ghobrial, Chia-Jen Liu, Robert A Redd, et al.
American Journal of Hematology|February 19, 2019
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk groupMark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Pageof 1